Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-03-21Clinical Trial Update: Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents
This clinical trial update examines how originator and biosimilar anti-TNF medications are used and how effective they are for rheumatoid ar…
-
FDA approval · 2018-03-20FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for Cimzia (certolizumab pegol) filed by UCB, Inc.
-
FDA approval · 2018-03-15FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
FDA approved a supplemental application for AMJEVITA (adalimumab-atto) submitted by Nuvaila Limited.
-
CLINICAL_TRIALS research · 2018-03-06Clinical Trial Update: Identification of New Prognostic Markers in Psoriatic Arthritis [NA]
This clinical trial update reports the identification of new prognostic markers in Psoriatic arthritis. The study, conducted at IRCCS Ospeda…
-
FDA approval · 2018-02-09FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for SIMPONI (golimumab) submitted by Janssen Biotech, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: A Study of Golimumab in Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 trial update for golimumab in active psoriatic arthritis has completed; results posted in 2017.
-
FDA approval · 2017-12-14FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ XR (tofacitinib) filed by Pfizer Laboratories Div Pfizer Inc, enabling the extended-rele…
-
CLINICAL_TRIALS trial_result · 2017-12-14Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 study of ixekizumab in active psoriatic arthritis has completed; results posted in 2017.
-
FDA approval · 2017-12-01FDA Approved: TALTZ — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for TALTZ (ixekizumab) submitted by Eli Lilly and Company, resulting in an expanded label for additi…
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial evaluating apremilast for active psoriatic arthritis using clinical assessments and a joint-periarticular-nail ultras…
-
FDA approval · 2017-10-13FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for ustekinumab (Stelara) from Janssen Biotech, Inc., potentially expanding indications or updat…
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: The NOR-SWITCH Study [Phase 4]
Phase 4 clinical trial update for NOR-SWITCH study; completed with multiple inflammatory diseases assessed.
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors [Phase 3]
Phase 3 trial of tofacitinib in psoriatic arthritis patients with inadequate response to TNF inhibitors has completed; results posted in 201…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: DC-STAMP & TRAF3: Regulators of Osteoclastogenesis and Biomarkers in PsA
An update on a completed clinical trial investigating the roles of DC-STAMP and TRAF3 as regulators of osteoclastogenesis and biomarkers in …
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX) [Phase 2]
AbbVie’s ABT-122 Phase 2 trial in active psoriatic arthritis completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis [Phase 3]
Phase 3 trial update on subcutaneous abatacept for active psoriatic arthritis reports efficacy and safety findings.
-
CLINICAL_TRIALS research · 2017-07-27Clinical Trial Update: Pharmacist CVD Intervention for Patients With Inflammatory Arthritis [NA]
Clinical trial update describing a pharmacist-led intervention to reduce cardiovascular risk in patients with inflammatory arthritis, includ…
-
CLINICAL_TRIALS withdrawal · 2017-07-17Clinical Trial Update: Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study [Phase 2]
This clinical trial update reports that the Phase 2 study evaluating liraglutide for psoriatic arthritis (and related conditions) has been w…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study [Phase 3]
Phase 3 trial update assessing the efficacy and safety of tofacitinib in psoriatic arthritis; results from the comparator study were posted …
-
FDA approval · 2017-06-30FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for ORENCIA (abatacept) submitted by E.R. Squibb & Sons, L.L.C. This action updates the product labe…
-
FDA approval · 2017-06-22FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for Simponi (golimumab) submitted by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis [Phase 3]
A Phase 3 study evaluating the efficacy, safety, and radiographic progression of brodalumab in psoriatic arthritis was terminated, with resu…
-
CLINICAL_TRIALS research · 2017-05-05Clinical Trial Update: The DIET Trial - Dietetic Intervention in Psoriatic Arthritis [NA]
Update on the DIET Trial evaluating a dietetic intervention for psoriatic arthritis with metabolic syndrome; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)
A completed clinical trial evaluating the impact of anti-TNF therapy on work and household productivity in patients with psoriatic arthritis…
-
FDA approval · 2017-04-21FDA Approved: RENFLEXIS — Original Application (Organon LLC)
The FDA approved RENFLEXIS (infliximab) from Organon LLC based on an original application, making it a biosimilar to Remicade. The approval …